<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35601378</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">1930-0433</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>17</Volume>
            <Issue>7</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>Radiology case reports</Title>
          <ISOAbbreviation>Radiol Case Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>MRI findings of autoimmune glial fibrillary acidic protein astrocytopathy involving infratentorial: Case report.</ArticleTitle>
        <Pagination>
          <StartPage>2515</StartPage>
          <EndPage>2518</EndPage>
          <MedlinePgn>2515-2518</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.radcr.2022.04.032</ELocationID>
        <Abstract>
          <AbstractText>Autoimmune glial fibrillary acidic protein astrocytopathy (GFAP-A) is a new type of autoimmune astrocytopathy first defined in 2016. Lack of clinical understanding, often misdiagnosed as optic neuromyelitis or multiple sclerosis. We report the clinical and MRI findings of an elderly patient with autoimmune glial fibrillary acidic protein astrocytopathy. With intractable vomiting as the first symptom, the brainstem showed typical vascular enhancement. GFAP-A lacks specificity in clinical and MRI scans. When enhancement reveals paraventricular "vascular-like enhancement" or central spinal cord tubular enhancement, it is important to consider the possibility of this disease.</AbstractText>
          <CopyrightInformation>© 2022 The Authors. Published by Elsevier Inc. on behalf of University of Washington.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ma</LastName>
            <ForeName>Wenhui</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, No. 926 Hospital, Joint Logistics Support Force of PLA, Kaiyuan, Yunnan 661699, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Cong</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, No. 926 Hospital, Joint Logistics Support Force of PLA, Kaiyuan, Yunnan 661699, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Lu</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, No. 926 Hospital, Joint Logistics Support Force of PLA, Kaiyuan, Yunnan 661699, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Luo</LastName>
            <ForeName>Junde</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, No. 926 Hospital, Joint Logistics Support Force of PLA, Kaiyuan, Yunnan 661699, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Radiol Case Rep</MedlineTA>
        <NlmUniqueID>101467888</NlmUniqueID>
        <ISSNLinking>1930-0433</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Autoimmune glial fibrillary acidic protein astrocytopathy</Keyword>
        <Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword>
        <Keyword MajorTopicYN="N">neuromyelitis optica spectrum disorders</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>23</Day>
          <Hour>4</Hour>
          <Minute>9</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35601378</ArticleId>
        <ArticleId IdType="pmc">PMC9114157</ArticleId>
        <ArticleId IdType="doi">10.1016/j.radcr.2022.04.032</ArticleId>
        <ArticleId IdType="pii">S1930-0433(22)00319-3</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Masaki K, Suzuki SO, Matsushita T, Matsushita T, Imamura S, Yamasaki R, et al.  Connexin 43 astrocytopathy linked to rapidly progressive multiple sclerosis and neuromyelitis optica[J] PLoS One. 2013;8(8):e72919.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3749992</ArticleId>
            <ArticleId IdType="pubmed">23991165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kira J. Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders[J] J Neurol Sci. 2011;311(1-2):69–77.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21962794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fang B, Mckeon A, Hinson SR, Kryzer TJ, Pittock S, Aksamit AJ, et al.  Autoimmune glial fibrillary acdic protein astrocytopathy: a novel meningoencephalomyelitis[J] JAMA Neurol. 2016;73(11):1297–1307.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27618707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Long Y, Liang J, Xu H, Huang Q, Yang J, Gao C, et al.  Autoimmune glial fibrillary acdic protein astrocytopathy in Chinses patients: a retrospective study[J] Eur J Neurol. 2018;25(3):477–483.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29193473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flanagan EP, Hinson S R, Lennon V A, Fang B, Aksamit AJ, Morris PP, et al.  Glial fibrillary acidic protein immunoglobulinG as biomarker of autoimmune astrocytopathy: analysis of 102 patients[J] Ann Neurol. 2017;81(2):298–309.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28120349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dubey D, Hinson SR, Jolliffe E A, Zekeridou A, Flanagan EP, Pittock SJ, et al.  Autoimmune GFAP astrocytopathy: prospective evaluation of 90 patients in 1 year[J] J Neuroimmunol, 2018;321:157–163.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29793728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kimura A, Takemura M, Yamamoto Y, Hayashi Y, Saito K, Shimohata T. Cytokines and biological markers in autoimmune GFAP astrocytopathy: the potential role for pathogenesis and therapeutic implications[J] J Neuroimmunol. 2019;334</Citation>
        </Reference>
        <Reference>
          <Citation>Iorio R, Damato V, Evoli A, Gessi M, Gaudino S, Lazzaro VD, et al.  Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients[J] J Neurol, Neurosurg &amp; Psychiatry. 2018;89(2):138–146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28951498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shan F, Long Y, Qiu W. Autoimmune glial fibrillary acdic protein astrocytopathy: a review of the literature[J] Front Immunol. 2018;9:2802.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6290896</ArticleId>
            <ArticleId IdType="pubmed">30568655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang X, Liang J, Huang Q, Xu HM, Gao C, Long YM, et al.  Treatment of autoimmune glial fibrillary acidic protein astrocytopathy: follow-up in 7 cases[J] Neuroimmunomodulation. 2017;24(2):113–119.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28922662</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
